142 Days Left

Canada-UK: Biomanufacturing of Biologics

Fund Name

Canada-UK: Biomanufacturing of Biologics and Advanced Therapies Round 2

Project Length

12-24 months

Project Value

£600k

Deadline

16.10.2024

UK registered organisations can apply for a share of up to £3 million for collaboration with Canadian SMEs on joint R&D projects, for enabling technologies and innovations in the biomanufacturing of biologics and advanced therapies.

This competition aims to stimulate the development and implementation of innovative technologies in biomanufacturing. The objective is to build the desired flexibility and technical capabilities required for the development and economically sustainable production of the next generation vaccines and therapies.

Check Your Eligibility

Fund details

Your joint Canadian and UK project can focus on one or more of the following:

Enabling technologies for biologics and advanced therapeutics

  • discovery, design and high throughput screening platforms, which may include the application of artificial intelligence
  • manufacturing systems and methods, for example: centralised, distributed or point‑of‑care; microfluidics‑based devices, new and innovative systems for Good Manufacturing Practice production, fill and finish, automation security
  • manufacturing process intensification enablers, for example hyper productive strains, novel expression systems, continuous production processes, perfusion technologies
  • novel analytical characterization, potency assays and real‑time release technologies, biosensors
  • other relevant enabling technologies

Delivery systems for proteins and nucleic acids

  • viral and non‑viral (for example, lipid nanoparticles) platforms, including their components and payloads

Novel biological products

  • vaccines, for example: prophylactic, therapeutic and various platforms
  • therapeutic proteins, for example: antibodies, and related production process‑intensification enablers
  • advanced therapy medicinal products, for example: mRNA, siRNA, gene therapies, cell therapies engineered tissues
  • other biological-based therapies, for example: bacteriophage, engineered probiotics

Eligibility

Canadian funding applicants are required to register and submit an expression of interest (EoI) before being eligible to apply for this competition.

The registration deadline for Canadian micro, small or medium-sized enterprises (SMEs) is 2 July 2024.

Projects must:

  • have a grant funding request of no more than £600,000 allocated to UK organisations
  • have a total grant funding request for Canadian partners of no more than CA$1 million

 

Contact us